Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 200

1.

Clinical relevance of arteriolar C4d staining in patients with chronic-active antibody-mediated rejection: A pilot study.

Snijders MLH, Sablik KA, van den Bosch TPP, Hesselink DA, Betjes MGH, Batal I, Clahsen-van Groningen MC.

Transplantation. 2019 Sep 9. doi: 10.1097/TP.0000000000002957. [Epub ahead of print]

PMID:
31517782
2.

Predictors of 90-Day Restart of Renal Replacement Therapy after Discontinuation of Continuous Renal Replacement Therapy, a Prospective Multicenter Study.

Stads S, Kant KM, de Jong MFC, de Ruijter W, Cobbaert CM, Betjes MGH, Gommers D, Oudemans-van Straaten HM.

Blood Purif. 2019;48(3):243-252. doi: 10.1159/000501387. Epub 2019 Jul 22.

3.

Banff lesions and renal allograft survival in chronic-active antibody mediated rejection.

Sablik KA, Clahsen-van Groningen MC, Damman J, Roelen DL, Betjes MGH.

Transpl Immunol. 2019 Oct;56:101213. doi: 10.1016/j.trim.2019.101213. Epub 2019 Jul 4.

PMID:
31279831
4.

Treatment with intravenous immunoglobulins and methylprednisolone may significantly decrease loss of renal function in chronic-active antibody-mediated rejection.

Sablik KA, Clahsen-van Groningen MC, Looman CWN, Damman J, van Agteren M, Betjes MGH.

BMC Nephrol. 2019 Jun 14;20(1):218. doi: 10.1186/s12882-019-1385-z.

5.

Antibodies against ARHGDIB are associated with long-term kidney graft loss.

Kamburova EG, Gruijters ML, Kardol-Hoefnagel T, Wisse BW, Joosten I, Allebes WA, van der Meer A, Hilbrands LB, Baas MC, Spierings E, Hack CE, van Reekum FE, van Zuilen AD, Verhaar MC, Bots ML, Drop ACAD, Plaisier L, Melchers RCA, Seelen MAJ, Sanders JS, Hepkema BG, Lambeck AJA, Bungener LB, Roozendaal C, Tilanus MGJ, Voorter CE, Wieten L, van Duijnhoven EM, Gelens MACJ, Christiaans MHL, van Ittersum FJ, Nurmohamed SA, Lardy NM, Swelsen W, van der Pant KAMI, van der Weerd NC, Ten Berge IJM, Hoitsma A, van der Boog PJM, de Fijter JW, Betjes MGH, Heidt S, Roelen DL, Claas FH, Bemelman FJ, Otten HG.

Am J Transplant. 2019 Jun 13. doi: 10.1111/ajt.15493. [Epub ahead of print]

PMID:
31194283
6.

Allocation to highly sensitized patients based on acceptable mismatches results in low rejection rates comparable to nonsensitized patients.

Heidt S, Haasnoot GW, Witvliet MD, van der Linden-van Oevelen MJH, Kamburova EG, Wisse BW, Joosten I, Allebes WA, van der Meer A, Hilbrands LB, Baas MC, Spierings E, Hack CE, van Reekum FE, van Zuilen AD, Verhaar MC, Bots ML, Drop ACAD, Plaisier L, Seelen MAJ, Sanders JS, Hepkema BG, Lambeck AJA, Bungener LB, Roozendaal C, Tilanus MGJ, Voorter CE, Wieten L, van Duijnhoven EM, Gelens MACJ, Christiaans MHL, van Ittersum FJ, Nurmohamed SA, Lardy NM, Swelsen W, van der Pant KAMI, van der Weerd NC, Ten Berge IJM, Bemelman FJ, Hoitsma A, van der Boog PJM, de Fijter JW, Betjes MGH, Otten HG, Roelen DL, Claas FHJ.

Am J Transplant. 2019 Oct;19(10):2926-2933. doi: 10.1111/ajt.15486. Epub 2019 Jul 1.

7.

Immunosuppressive drug withdrawal late after liver transplantation improves the lipid profile and reduces infections.

Duizendstra AA, de Knegt RJ, Betjes MGH, Coenen S, Murad SD, de Man RA, Metselaar HJ, Sprengers D, Litjens NHR, Kwekkeboom J.

Eur J Gastroenterol Hepatol. 2019 Nov;31(11):1444-1451. doi: 10.1097/MEG.0000000000001435.

PMID:
31095525
8.

Disrupted regulation of serpinB9 in circulating T cells is associated with an increased risk for post-transplant skin cancer.

Peters FS, Peeters AMA, van den Bosch TPP, Mooyaart AL, van de Wetering J, Betjes MGH, Baan CC, Boer K.

Clin Exp Immunol. 2019 Sep;197(3):341-351. doi: 10.1111/cei.13309. Epub 2019 May 30.

9.

Predictors of short-term successful discontinuation of continuous renal replacement therapy: results from a prospective multicentre study.

Stads S, Kant KM, de Jong MFC, de Ruijter W, Cobbaert CM, Betjes MGH, Gommers D, Oudemans-van Straaten HM.

BMC Nephrol. 2019 Apr 15;20(1):129. doi: 10.1186/s12882-019-1327-9.

10.

Effects of bariatric surgery on telomere length and T-cell aging.

Jongbloed F, Meijers RWJ, IJzermans JNM, Klaassen RA, Dollé MET, van den Berg S, Betjes MGH, de Bruin RWF, van der Harst E, Litjens NHR.

Int J Obes (Lond). 2019 Nov;43(11):2189-2199. doi: 10.1038/s41366-019-0351-y. Epub 2019 Apr 12.

PMID:
30979972
11.

Increased CD16 expression on NK cells is indicative of antibody-dependent cell-mediated cytotoxicity in chronic-active antibody-mediated rejection.

Sablik KA, Litjens NHR, Klepper M, Betjes MGH.

Transpl Immunol. 2019 Jun;54:52-58. doi: 10.1016/j.trim.2019.02.005. Epub 2019 Feb 19.

PMID:
30794946
12.

The aftermath of acute kidney injury: a narrative review of long-term mortality and renal function.

Fortrie G, de Geus HRH, Betjes MGH.

Crit Care. 2019 Jan 24;23(1):24. doi: 10.1186/s13054-019-2314-z. Review.

13.

Development and Validation of a Multiplex Non-HLA Antibody Assay for the Screening of Kidney Transplant Recipients.

Kamburova EG, Kardol-Hoefnagel T, Wisse BW, Joosten I, Allebes WA, van der Meer A, Hilbrands LB, Baas MC, Spierings E, Hack CE, van Reekum FE, van Zuilen AD, Verhaar MC, Bots ML, Drop ACAD, Plaisier L, Meeldijk J, Bovenschen N, Seelen MAJ, Sanders JS, Hepkema BG, Lambeck AJA, Bungener LB, Roozendaal C, Tilanus MGJ, Voorter CE, Wieten L, van Duijnhoven EM, Gelens MACJ, Christiaans MHL, van Ittersum FJ, Nurmohamed SA, Lardy NM, Swelsen W, van der Pant KAMI, van der Weerd NC, Ten Berge IJM, Bemelman FJ, van der Boog PJM, de Fijter JW, Betjes MGH, Heidt S, Roelen DL, Claas FH, Otten HG.

Front Immunol. 2018 Dec 19;9:3002. doi: 10.3389/fimmu.2018.03002. eCollection 2018.

14.

Effect of initial immunosuppression on long-term kidney transplant outcome in immunological low-risk patients.

Michielsen LA, van Zuilen AD, Verhaar MC, Wisse BW, Kamburova EG, Joosten I, Allebes WA, van der Meer A, Baas MC, Spierings E, Hack CE, van Reekum FE, Bots ML, Drop ACAD, Plaisier L, Seelen MAJ, Sanders JF, Hepkema BG, Lambeck AJ, Bungener LB, Roozendaal C, Tilanus MGJ, Voorter CE, Wieten L, van Duijnhoven EM, Gelens MACJ, Christiaans MHL, van Ittersum FJ, Nurmohamed SA, Lardy NM, Swelsen W, van der Pant KA, van der Weerd NC, Ten Berge IJM, Bemelman FJ, Hoitsma A, van der Boog PJM, de Fijter JW, Betjes MGH, Heidt S, Roelen DL, Claas FH, Otten HG, Hilbrands LB.

Nephrol Dial Transplant. 2018 Dec 15. doi: 10.1093/ndt/gfy377. [Epub ahead of print]

PMID:
30561730
15.

A comprehensive characterization of aggravated aging-related changes in T lymphocytes and monocytes in end-stage renal disease: the iESRD study.

Chiu YL, Shu KH, Yang FJ, Chou TY, Chen PM, Lay FY, Pan SY, Lin CJ, Litjens NHR, Betjes MGH, Bermudez S, Kao KC, Chia JS, Wang G, Peng YS, Chuang YF.

Immun Ageing. 2018 Nov 8;15:27. doi: 10.1186/s12979-018-0131-x. eCollection 2018.

16.

Erratum.

Kers J, Peters-Sengers H, Heemskerk MBA, Berger SP, Betjes MGH, van Zuilen AD, Hilbrands LB, de Fijter JW, Nurmohamed AS, Christiaans MH, Homan van der Heide JJ, Debray TPA, Bemelman FJ.

Nephrol Dial Transplant. 2018 Oct 29. doi: 10.1093/ndt/gfy353. [Epub ahead of print] No abstract available.

PMID:
30376111
17.

A paired kidney analysis on the impact of pre-transplant anti-HLA antibodies on graft survival.

Michielsen LA, Wisse BW, Kamburova EG, Verhaar MC, Joosten I, Allebes WA, van der Meer A, Hilbrands LB, Baas MC, Spierings E, Hack CE, van Reekum FE, Bots ML, Drop ACAD, Plaisier L, Seelen MAJ, Sanders JF, Hepkema BG, Lambeck AJ, Bungener LB, Roozendaal C, Tilanus MGJ, Voorter CE, Wieten L, van Duijnhoven EM, Gelens M, Christiaans MHL, van Ittersum FJ, Nurmohamed SA, Lardy NM, Swelsen W, van der Pant KA, van der Weerd NC, Ten Berge IJM, Bemelman FJ, Hoitsma A, van der Boog PJM, de Fijter JW, Betjes MGH, Heidt S, Roelen DL, Claas FH, Otten HG, van Zuilen AD.

Nephrol Dial Transplant. 2019 Jun 1;34(6):1056-1063. doi: 10.1093/ndt/gfy316.

PMID:
30365008
18.

Toward a Sensible Single-antigen Bead Cutoff Based on Kidney Graft Survival.

Wisse BW, Kamburova EG, Joosten I, Allebes WA, van der Meer A, Hilbrands LB, Baas MC, Spierings E, Hack CE, van Reekum FE, van Zuilen AD, Verhaar MC, Bots ML, Drop ACAD, Plaisier L, Seelen MAJ, Stephan Sanders J, Hepkema BG, Lambeck AJA, Bungener LB, Roozendaal C, Tilanus MGJ, Voorter CE, Wieten L, van Duijnhoven EM, Gelens MACJ, Christiaans MHL, van Ittersum FJ, Nurmohamed SA, Lardy NM, Swelsen W, van der Pant KAMI, van der Weerd NC, Ten Berge IJM, Bemelman FJ, Hoitsma AJ, van der Boog PJM, de Fijter JW, Betjes MGH, Heidt S, Roelen DL, Claas FH, Otten HG.

Transplantation. 2019 Apr;103(4):789-797. doi: 10.1097/TP.0000000000002357.

19.

Pretransplant C3d-Fixing Donor-Specific Anti-HLA Antibodies Are Not Associated with Increased Risk for Kidney Graft Failure.

Kamburova EG, Wisse BW, Joosten I, Allebes WA, van der Meer A, Hilbrands LB, Baas MC, Spierings E, Hack CE, van Reekum FE, van Zuilen AD, Verhaar MC, Bots ML, Drop ACAD, Plaisier L, Seelen MAJ, Sanders JS, Hepkema BG, Lambeck AJA, Bungener LB, Roozendaal C, Tilanus MGJ, Voorter CE, Wieten L, van Duijnhoven EM, Gelens MACJ, Christiaans MHL, van Ittersum FJ, Nurmohamed SA, Lardy NM, Swelsen W, van der Pant KAMI, van der Weerd NC, Ten Berge IJM, Bemelman FJ, Hoitsma AJ, van der Boog PJM, de Fijter JW, Betjes MGH, Heidt S, Roelen DL, Claas FH, Otten HG.

J Am Soc Nephrol. 2018 Sep;29(9):2279-2285. doi: 10.1681/ASN.2018020205. Epub 2018 Jul 26.

20.

ABO-Incompatible Kidney Transplant Outcomes: A Meta-Analysis.

de Weerd AE, Betjes MGH.

Clin J Am Soc Nephrol. 2018 Aug 7;13(8):1234-1243. doi: 10.2215/CJN.00540118. Epub 2018 Jul 16.

21.

Differentially methylated regions in T cells identify kidney transplant patients at risk for de novo skin cancer.

Peters FS, Peeters AMA, Mandaviya PR, van Meurs JBJ, Hofland LJ, van de Wetering J, Betjes MGH, Baan CC, Boer K.

Clin Epigenetics. 2018 Jun 18;10:81. doi: 10.1186/s13148-018-0519-7. eCollection 2018.

22.

Tacrolimus intra-patient variability is not associated with chronic active antibody mediated rejection.

Sablik KA, Clahsen-van Groningen MC, Hesselink DA, van Gelder T, Betjes MGH.

PLoS One. 2018 May 10;13(5):e0196552. doi: 10.1371/journal.pone.0196552. eCollection 2018.

23.

Chronic-active antibody-mediated rejection with or without donor-specific antibodies has similar histomorphology and clinical outcome - a retrospective study.

Sablik KA, Clahsen-van Groningen MC, Looman CWN, Damman J, Roelen DL, van Agteren M, Betjes MGH.

Transpl Int. 2018 Aug;31(8):900-908. doi: 10.1111/tri.13154. Epub 2018 Apr 16.

24.

PIRCHE-II Is Related to Graft Failure after Kidney Transplantation.

Geneugelijk K, Niemann M, Drylewicz J, van Zuilen AD, Joosten I, Allebes WA, van der Meer A, Hilbrands LB, Baas MC, Hack CE, van Reekum FE, Verhaar MC, Kamburova EG, Bots ML, Seelen MAJ, Sanders JS, Hepkema BG, Lambeck AJ, Bungener LB, Roozendaal C, Tilanus MGJ, Vanderlocht J, Voorter CE, Wieten L, van Duijnhoven EM, Gelens M, Christiaans MHL, van Ittersum FJ, Nurmohamed A, Lardy JNM, Swelsen W, van der Pant KA, van der Weerd NC, Ten Berge IJM, Bemelman FJ, Hoitsma A, van der Boog PJM, de Fijter JW, Betjes MGH, Heidt S, Roelen DL, Claas FH, Otten HG, Spierings E.

Front Immunol. 2018 Mar 5;9:321. doi: 10.3389/fimmu.2018.00321. eCollection 2018.

25.

A Successful Approach to Kidney Transplantation in Patients With Enteric (Secondary) Hyperoxaluria.

Roodnat JI, de Mik-van Egmond AME, Visser WJ, Berger SP, van der Meijden WAG, Knauf F, van Agteren M, Betjes MGH, Hoorn EJ.

Transplant Direct. 2017 Nov 8;3(12):e331. doi: 10.1097/TXD.0000000000000748. eCollection 2017 Dec.

26.

Differential effects of donor-specific HLA antibodies in living versus deceased donor transplant.

Kamburova EG, Wisse BW, Joosten I, Allebes WA, van der Meer A, Hilbrands LB, Baas MC, Spierings E, Hack CE, van Reekum FE, van Zuilen AD, Verhaar MC, Bots ML, Drop ACAD, Plaisier L, Seelen MAJ, Sanders JSF, Hepkema BG, Lambeck AJA, Bungener LB, Roozendaal C, Tilanus MGJ, Voorter CE, Wieten L, van Duijnhoven EM, Gelens M, Christiaans MHL, van Ittersum FJ, Nurmohamed SA, Lardy NM, Swelsen W, van der Pant KA, van der Weerd NC, Ten Berge IJM, Bemelman FJ, Hoitsma A, van der Boog PJM, de Fijter JW, Betjes MGH, Heidt S, Roelen DL, Claas FH, Otten HG.

Am J Transplant. 2018 Sep;18(9):2274-2284. doi: 10.1111/ajt.14709. Epub 2018 Apr 16.

27.

Predicition models for delayed graft function: external validation on The Dutch Prospective Renal Transplantation Registry.

Kers J, Peters-Sengers H, Heemskerk MBA, Berger SP, Betjes MGH, van Zuilen AD, Hilbrands LB, de Fijter JW, Nurmohamed AS, Christiaans MH, Homan van der Heide JJ, Debray TPA, Bemelman FJ.

Nephrol Dial Transplant. 2018 Jul 1;33(7):1259-1268. doi: 10.1093/ndt/gfy019.

PMID:
29462353
28.

Immunomodulation By Therapeutic Mesenchymal Stromal Cells (MSC) Is Triggered Through Phagocytosis of MSC By Monocytic Cells.

de Witte SFH, Luk F, Sierra Parraga JM, Gargesha M, Merino A, Korevaar SS, Shankar AS, O'Flynn L, Elliman SJ, Roy D, Betjes MGH, Newsome PN, Baan CC, Hoogduijn MJ.

Stem Cells. 2018 Apr;36(4):602-615. doi: 10.1002/stem.2779. Epub 2018 Feb 1.

29.

End-Stage Renal Disease Causes Skewing in the TCR Vβ-Repertoire Primarily within CD8+ T Cell Subsets.

Huang L, Betjes MGH, Klepper M, Langerak AW, Baan CC, Litjens NHR.

Front Immunol. 2017 Dec 15;8:1826. doi: 10.3389/fimmu.2017.01826. eCollection 2017.

30.

T-Cell Composition of the Lymph Node Is Associated with the Risk for Early Rejection after Renal Transplantation.

Dedeoglu B, Litjens NHR, de Weerd AE, Dor FJ, Klepper M, Reijerkerk D, Baan CC, Betjes MGH.

Front Immunol. 2017 Oct 27;8:1416. doi: 10.3389/fimmu.2017.01416. eCollection 2017.

31.

Protective Cytomegalovirus (CMV)-Specific T-Cell Immunity Is Frequent in Kidney Transplant Patients without Serum Anti-CMV Antibodies.

Litjens NHR, Huang L, Dedeoglu B, Meijers RWJ, Kwekkeboom J, Betjes MGH.

Front Immunol. 2017 Sep 12;8:1137. doi: 10.3389/fimmu.2017.01137. eCollection 2017.

32.

Inflammatory Conditions Dictate the Effect of Mesenchymal Stem or Stromal Cells on B Cell Function.

Luk F, Carreras-Planella L, Korevaar SS, de Witte SFH, Borràs FE, Betjes MGH, Baan CC, Hoogduijn MJ, Franquesa M.

Front Immunol. 2017 Aug 28;8:1042. doi: 10.3389/fimmu.2017.01042. eCollection 2017.

33.

CD4+ CD28null T cells are not alloreactive unless stimulated by interleukin-15.

Dedeoglu B, Litjens NHR, Klepper M, Kraaijeveld R, Verschoor W, Baan CC, Betjes MGH.

Am J Transplant. 2018 Feb;18(2):341-350. doi: 10.1111/ajt.14480. Epub 2017 Oct 2.

34.

Interferon-Gamma DNA Methylation Is Affected by Mycophenolic Acid but Not by Tacrolimus after T-Cell Activation.

Peters FS, Peeters AMA, Hofland LJ, Betjes MGH, Boer K, Baan CC.

Front Immunol. 2017 Jul 12;8:822. doi: 10.3389/fimmu.2017.00822. eCollection 2017.

35.

The truth on current peritoneal dialysis: state of the art.

Krediet RT, Abrahams AC, de Fijter CWH, Betjes MGH, Boer WH, van Jaarsveld BC, Konings CJAM, Dekker FW.

Neth J Med. 2017 Jun;75(5):179-189. Review.

36.

pERK-dependent defective TCR-mediated activation of CD4+ T cells in end-stage renal disease patients.

Huang L, Litjens NHR, Kannegieter NM, Klepper M, Baan CC, Betjes MGH.

Immun Ageing. 2017 Jun 19;14:14. doi: 10.1186/s12979-017-0096-1. eCollection 2017.

37.

Significant Decreasing Incidence of Encapsulating Peritoneal Sclerosis in the Dutch Population of Peritoneal Dialysis Patients.

Betjes MG, Habib SM, Boeschoten EW, Hemke AC, Struijk DG, Westerhuis R, Abrahams AC, Korte MR.

Perit Dial Int. 2017 Mar-Apr;37(2):230-234. doi: 10.3747/pdi.2016.00109.

PMID:
28360369
38.

Kidney transplantation in patients declined by other centres.

Glijn NH, Roodnat JI, Dor FJ, Betjes MG, Zuidema WC, Weimar W, Berger SP.

Neth J Med. 2017 Mar;75(2):74-80.

39.

Renal function at 1 year after cardiac transplantation rather than acute kidney injury is highly associated with long-term patient survival and loss of renal function - a retrospective cohort study.

Fortrie G, Manintveld OC, Constantinescu AA, van de Woestijne PC, Betjes MGH.

Transpl Int. 2017 Aug;30(8):788-798. doi: 10.1111/tri.12940.

40.

Lymph node and circulating T cell characteristics are strongly correlated in end-stage renal disease patients, but highly differentiated T cells reside within the circulation.

Dedeoglu B, de Weerd AE, Huang L, Langerak AW, Dor FJ, Klepper M, Verschoor W, Reijerkerk D, Baan CC, Litjens NH, Betjes MG.

Clin Exp Immunol. 2017 May;188(2):299-310. doi: 10.1111/cei.12934. Epub 2017 Feb 28.

41.

Natural regulatory T cells from patients with end-stage renal disease can be used for large-scale generation of highly suppressive alloantigen-specific Tregs.

Litjens NH, Boer K, Zuijderwijk JM, Klepper M, Peeters AM, Verschoor W, Kraaijeveld R, Betjes MG.

Kidney Int. 2017 May;91(5):1203-1213. doi: 10.1016/j.kint.2016.09.043. Epub 2016 Dec 15.

PMID:
27988212
42.

Variations in DNA methylation of interferon gamma and programmed death 1 in allograft rejection after kidney transplantation.

Boer K, de Wit LE, Peters FS, Hesselink DA, Hofland LJ, Betjes MG, Looman CW, Baan CC.

Clin Epigenetics. 2016 Nov 16;8:116. eCollection 2016.

43.

Stretching the Limits of Renal Transplantation in Elderly Recipients of Grafts from Elderly Deceased Donors.

Peters-Sengers H, Berger SP, Heemskerk MB, Al Arashi D, Homan van der Heide JJ, Hemke AC, Ten Berge IJ, Idu MM, Betjes MG, van Zuilen AD, Hilbrands LB, de Vries AP, Nurmohamed AS, Christiaans MH, Ernest van Heurn LW, de Fijter JW, Bemelman FJ.

J Am Soc Nephrol. 2017 Feb;28(2):621-631. doi: 10.1681/ASN.2015080879. Epub 2016 Oct 11.

44.

Minimizing the Number of Urological Complications After Kidney Transplant: A Comparative Study of Two Types of External Ureteral Stents.

Ooms LS, Spaans LG, Betjes MG, Ijzermans JN, Terkivatan T.

Exp Clin Transplant. 2017 Apr;15(2):143-149. doi: 10.6002/ect.2016.0051. Epub 2016 Aug 24.

45.

How can we reduce costs of solid-phase multiplex-bead assays used to determine anti-HLA antibodies?

Kamburova EG, Wisse BW, Joosten I, Allebes WA, van der Meer A, Hilbrands LB, Baas MC, Spierings E, Hack CE, van Reekum FE, van Zuilen AD, Verhaar M, Bots ML, Drop AC, Plaisier L, Seelen MA, Sanders JS, Hepkema BG, Lambeck AJ, Bungener LB, Roozendaal C, Tilanus MG, Vanderlocht J, Voorter CE, Wieten L, van Duijnhoven EM, Gelens M, Christiaans MH, van Ittersum FJ, Nurmohamed A, Lardy NM, Swelsen W, van der Pant KA, van der Weerd NC, Ten Berge IJ, Bemelman FJ, Hoitsma A, van der Boog PJ, de Fijter JW, Betjes MG, Heidt S, Roelen DL, Claas FH, Otten HG.

HLA. 2016 Sep;88(3):110-9. doi: 10.1111/tan.12860. Epub 2016 Aug 18.

PMID:
27534609
46.

Alemtuzumab as Antirejection Therapy: T Cell Repopulation and Cytokine Responsiveness.

Bouvy AP, Klepper M, Betjes MG, Weimar W, Hesselink DA, Baan CC.

Transplant Direct. 2016 May 25;2(6):e83. doi: 10.1097/TXD.0000000000000595. eCollection 2016 Jun.

47.

Latency for cytomegalovirus impacts T cell ageing significantly in elderly end-stage renal disease patients.

Huang L, Langerak AW, Baan CC, Litjens NH, Betjes MG.

Clin Exp Immunol. 2016 Nov;186(2):239-248. doi: 10.1111/cei.12846. Epub 2016 Aug 19.

48.

Inactivated Mesenchymal Stem Cells Maintain Immunomodulatory Capacity.

Luk F, de Witte SF, Korevaar SS, Roemeling-van Rhijn M, Franquesa M, Strini T, van den Engel S, Gargesha M, Roy D, Dor FJ, Horwitz EM, de Bruin RW, Betjes MG, Baan CC, Hoogduijn MJ.

Stem Cells Dev. 2016 Sep 15;25(18):1342-54. doi: 10.1089/scd.2016.0068. Epub 2016 Aug 9.

PMID:
27349989
49.

Similar 5-Year Estimated Glomerular Filtration Rate Between Kidney Transplants From Uncontrolled and Controlled Donors After Circulatory Death-A Dutch Cohort Study.

Peters-Sengers H, Homan van der Heide JJ, Heemskerk MBA, Ten Berge IJM, Ultee FCW, Idu MM, Betjes MGH, van Zuilen AD, Christiaans MHL, Hilbrands LH, de Vries APJ, Nurmohamed AS, Berger SP, Bemelman FJ.

Transplantation. 2017 Jun;101(6):1144-1151. doi: 10.1097/TP.0000000000001211.

50.

Clinical potential of DNA methylation in organ transplantation.

Peters FS, Manintveld OC, Betjes MG, Baan CC, Boer K.

J Heart Lung Transplant. 2016 Jul;35(7):843-50. doi: 10.1016/j.healun.2016.02.007. Epub 2016 Mar 10.

PMID:
27085975

Supplemental Content

Loading ...
Support Center